Dishman Pharmaceuticals And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 33.00 Cr
as on 08-05-2024
- Paid Up Capital ₹ 32.28 Cr
as on 08-05-2024
- Company Age 41 Year, 5 Months
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 1,401.19 Cr
as on 08-05-2024
- Revenue 2.25%
(FY 2016)
- Profit 49.03%
(FY 2016)
- Ebitda 15.26%
(FY 2016)
- Net Worth 8.98%
(FY 2016)
- Total Assets 1.87%
(FY 2016)
About Dishman Pharmaceuticals And Chemicals
- CIN/LLPIN
L24230GJ1983PLC006329
- Company No.
006329
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Jun 1983
- Date of AGM
27 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dishman Pharmaceuticals And Chemicals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Janmejay Vyas  | Managing Director | 29-Jun-1983 | Current |
| Arpit Vyas | Managing Director | 01-Jun-2009 | Current |
| Shrima Dave | Company Secretary | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subir Das | Director | 15-Dec-2014 | Current |
| Rajendra Shah | Director | 02-Apr-2015 | Current |
Mark Griffiths  | Director | 01-Sep-2014 | Current |
| Deohooti Vyas | Whole-Time Director | 01-Dec-1997 | Current |
| Ashok Gandhi | Director | 30-Jul-2004 | Current |
| Sanjay Majmudar | Director | 14-Feb-2004 | Current |
Financial Performance and Corporate Structure Insights of Dishman Pharmaceuticals And Chemicals.
Dishman Pharmaceuticals And Chemicals Limited, for the financial year ended 2016, experienced modest growth in revenue, with a 2.25% increase. The company also saw a substantial improvement in profitability, with a 49.03% increase in profit. The company's net worth moved up by a moderate rise of 8.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dishman Pharmaceuticals And Chemicals?
In 2016, Dishman Pharmaceuticals And Chemicals had a promoter holding of 61.40% and a public holding of 38.60%. The company had 3 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dishman Carbogen Amcis LimitedActive 17 years 5 monthsJanmejay Vyas, Deohooti Vyas and 4 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Jul 2016 | ₹44.00 Cr | Satisfied |
Citi Bank N.A. Creation Date: 21 Apr 2016 | ₹50.00 Cr | Satisfied |
Tamilnad Mercantile Bank Limited Creation Date: 24 Sep 2015 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Dishman Pharmaceuticals And Chemicals?
Dishman Pharmaceuticals And Chemicals has a workforce of 1116 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dishman Pharmaceuticals And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dishman Pharmaceuticals And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
